From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockland, MD 20857, USA.
D015492:AIDS Serodiagnosis; D000329:Advertising; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D003257:Consumer Product Safety; D005277:Fenfluramine / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000175:diagnosis; D015497:HIV-1; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D011356:Product Labeling; D011933:Reagent Kits, Diagnostic; D014481:United States; D014486:United States Food and Drug Administration
D001067:Appetite Depressants; D011933:Reagent Kits, Diagnostic; D005277:Fenfluramine